These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6688661)

  • 1. The effect of a vasopressin antagonist on the pressor response to histamine administered centrally.
    Gatti PJ; Gertner SB
    Neuropharmacology; 1983 Jul; 22(7):895-902. PubMed ID: 6688661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrelationship between central bradykinin and vasopressin in conscious rats.
    Brooks DP; Share L; Crofton JT; Nasjletti A
    Brain Res; 1986 Apr; 371(1):42-8. PubMed ID: 3754782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral mechanisms involved in the pressor and bradycardic effects of centrally administered arachidonic acid.
    Aydin C; Yalcin M
    Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):361-8. PubMed ID: 18571395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin pressor antagonist injected centrally reverses behavioral effects of peripheral injection of vasopressin, but only at doses that reverse increase in blood pressure.
    Lebrun C; Le Moal M; Koob GF; Bloom FE
    Regul Pept; 1985 Jun; 11(2):173-81. PubMed ID: 4035008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged inhibition of pressor response to vasopressin by a potent specific antagonist, [1-(beta-mercapto-beta, beta-cyclopentamethylenepropionic acid) 2-(O-methyl)tyrosine]arginine-vasopressin.
    Pang CC; Leighton KM
    Can J Physiol Pharmacol; 1981 Sep; 59(9):1008-12. PubMed ID: 6895346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of angiotensin II receptors inhibits the increase in blood pressure induced by insulin.
    Nakata T; Takeda K; Hatta T; Kiyama M; Moriguchi J; Miki S; Kawa T; Morimoto S; Nakamura K; Uchida A; Itoh H; Sasaki S; Nakagawa M
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):248-52. PubMed ID: 9475266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central vasopressin raises arterial pressure by sympathetic activation and vasopressin release.
    Janiak P; Kasson BG; Brody MJ
    Hypertension; 1989 Jun; 13(6 Pt 2):935-40. PubMed ID: 2737730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABA agonists inhibit the vasopressin-dependent pressor effects of central angiotensin II.
    Brennan TJ; Morris M; Haywood JR
    Neuroendocrinology; 1984 Nov; 39(5):429-36. PubMed ID: 6514131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanism of the cardiovascular action of central injections of histamine.
    Klein MC; Gertner SB
    Neuropharmacology; 1983 Sep; 22(9):1109-15. PubMed ID: 6138730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA agonists inhibit central sodium-induced vasopressin-dependent increases in arterial pressure.
    Brennan TJ; Morris M; Haywood JR
    Eur J Pharmacol; 1984 Aug; 103(3-4):223-34. PubMed ID: 6489442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choline administration reverses hypotension in spinal cord transected rats: the involvement of vasopressin.
    Savci V; Ulus IH
    Neurochem Res; 1998 May; 23(5):733-41. PubMed ID: 9566613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurohumoral contributions to chronic angiotensin-induced hypertension.
    Bruner CA; Fink GD
    Am J Physiol; 1986 Jan; 250(1 Pt 2):H52-61. PubMed ID: 2867686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system.
    Savci V; Cavun S; Goktalay G; Ulus IH
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):388-98. PubMed ID: 12012025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that centrally released arginine vasopressin is involved in central pressor action of angiotensin II.
    Loń S; Szczepańska-Sadowska E; Szczypaczewska M
    Am J Physiol; 1996 Jan; 270(1 Pt 2):H167-73. PubMed ID: 8769748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin: mechanism of central cardiovascular action in conscious rats.
    Rohmeiss P; Becker H; Dietrich R; Luft F; Unger T
    J Cardiovasc Pharmacol; 1986; 8(4):689-96. PubMed ID: 2427805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular effects of arginine vasopressin during fluid deprivation in the rat.
    Aisenbrey GA; Handelman WA; Arnold P; Manning M; Schrier RW
    J Clin Invest; 1981 Apr; 67(4):961-8. PubMed ID: 7204578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centrally administered interleukin-1 beta sensitizes to the central pressor action of angiotensin II.
    Ufnal M; Dudek M; Zera T; Szczepańska-Sadowska E
    Brain Res; 2006 Jul; 1100(1):64-72. PubMed ID: 16765325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebroventricular treatment with vasopressin V1-receptor antagonist inhibits centrally-mediated pressor response to clonidine in conscious rats.
    Nakamura S; Kawasaki H; Takasaki K
    Jpn J Pharmacol; 1993 Dec; 63(4):447-53. PubMed ID: 8121079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of arginine vasopressin and angiotensin II in cardiovascular responses to combined acute hypoxemia and hypercapnic acidosis in conscious dogs.
    Rose CE; Godine RL; Rose KY; Anderson RJ; Carey RM
    J Clin Invest; 1984 Aug; 74(2):321-31. PubMed ID: 6547729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of vasopressin in cardiovascular response to central cholinergic stimulation in rats.
    Imai Y; Abe K; Sasaki S; Minami N; Munakata M; Yumita S; Nobunaga T; Sekino H; Yoshinaga K
    Hypertension; 1989 Jun; 13(6 Pt 1):549-57. PubMed ID: 2737706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.